The clearest part is the choice
Strut lists an injectable monthly vial at $119 and a 30-day oral supply at $99. Consultations and shipping are included in the stated prices. That makes the basic commercial choice readable. The medical choice remains separate: sharing an ingredient does not establish equal absorption, benefit or instructions. Pick a route through a clinical discussion before treating the cheaper line as the better purchase.
Two routines, two evidence questions
A lozenge avoids needles; an injection adds handling and supplies. Those differences matter in daily life. Historical injected-sermorelin findings cannot simply establish the oral product’s effects, and neither route should inherit a guarantee from a general growth-hormone explanation. The formulation needs to match the evidence being discussed. An attractive choice of formats is useful only when their limitations stay visible.
Included visits help the comparison
Strut says physician consultations, messaging and follow-ups accompany care. That gives the listed price more substance than a vial charge alone. Additional testing could still change the commitment. The selected agreement should explain what is included, which clinician handles symptoms and when a fuller assessment is needed. A follow-up promise is most valuable when its purpose and practical availability are clear.
Auto-refill needs an understandable exit
The page advertises cancellation, but a prepared pharmacy order may have different conditions from future renewals. Settle that distinction before payment. The same applies to shipping problems and product changes. The dispensing pharmacy should supply preparation-specific instructions and the usable period. These are ordinary parts of an ongoing service, and clarity here can matter more than a broad promise of continuing support.
Who it suits
Strut deserves a shortlist position for readers who appreciate separate format pricing and included consultations. Compare its oral option with Ivím’s, including membership and supply interval; compare the injection with an equivalent injectable offer. Keep extra testing and refund terms beside the final charge. The next step is a product-specific clinical explanation, followed by the contract for that product, rather than a decision based on route preference alone.
Understanding the cost
Listed at $119 for an injectable monthly vial or $99 for a 30-day oral supply, with consultations and shipping; clarify extra testing and prepared-order refunds.
Build your cost estimateSources
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.